| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1996) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | D05BB02 |
| UNII: | LCH760E9T7 |
Structure
| InChI Key | IHUNBGSDBOWDMA-AQFIFDHZSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C21H26O3 |
| Molecular Weight | 326.44 |
| AlogP | 5.17 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 46.53 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 24.0 |
Pharmacology
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Transporter
Primary active transporter
ATP-binding cassette
ABCB subfamily
|
- | 18200-38200 | - | - | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | 49000 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Psoriasis | 4 | D011565 | ClinicalTrials |
| Alzheimer Disease | 2 | D000544 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Dermatitis | 2 | D003872 | ClinicalTrials |
| HIV Infections | 1 | D015658 | ClinicalTrials |
Related Entries
MCS
Side Effects from Label
Side Effects (PT)
| Side effects | Relative Frequency (%) | Labels | |
|---|---|---|---|
| Investigations Blood triglycerides increased | 65.0 | ||
| Metabolism and nutrition disorders Hypertriglyceridaemia | 65.0 | ||
| Eye disorders Dry eye | 30.0 | ||
| Investigations Blood uric acid increased | 17.0 | ||
| Metabolism and nutrition disorders Hypercholesterolaemia | 9.0 | ||
| Investigations White blood cell count decreased | 7.0 | ||
| Investigations Blood creatinine increased | 5.0 | ||
| Renal and urinary disorders Glycosuria | 4.0 | ||
| Renal and urinary disorders Ketonuria | 3.0 | ||
| Renal and urinary disorders Proteinuria | 2.0 | ||
| Investigations Protein urine present | 2.0 | ||
| Benign intracranial hypertension | 1.0 | ||
| Eye disorders Night blindness | 1.0 |
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 55079-83-9 |
| ChEBI | 50173 |
| ChEMBL | CHEMBL1131 |
| DrugBank | DB00459 |
| DrugCentral | 78 |
| EPA CompTox | DTXSID6022553 |
| FDA SRS | LCH760E9T7 |
| Guide to Pharmacology | 7598 |
| PubChem | 5284513 |
| SureChEMBL | SCHEMBL3759 |
| ZINC | ZINC000003798734 |
CONTENTS